Lymphopenia as prognostic factor for mortality and hospital length of stay for elderly hospitalized patients

Manuel Rubio-Rivas1, Francesc Formiga2, Sara Grillo1, Francesca Gili1, Celina Cabrera1, Xavier Corbella1,3
1Internal Medicine Department, Bellvitge University Hospital-IDIBELL, L’Hospitalet de Llobregat, Spain
2Geriatric Unit, Internal Medicine Department, Bellvitge University Hospital-IDIBELL, L’Hospitalet de Llobregat, Spain
3Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain

Tóm tắt

Lymphopenia is a common finding in elderly patients and its relevance is unknown. To evaluate the clinical prognostic value of lymphopenia on the admission of elderly hospitalized patients. From 2012 to 2013, all consecutive patients >75 hospitalized because of medical conditions were prospectively included in the study. Sociodemographic, clinical and laboratory data were collected. Lymphopenia was considered by a plasmatic lymphocyte count of <1100 × 109/l. Hospital length of stay, in-hospital mortality and mortality after a 1-year follow-up were assessed. The total sample consisted of 180 patients, 90 of whom were females (50 %). Mean age was 83.8 years (SD 5.4). Lymphopenia was present in 45 patients (25 %) upon admission. When compared, those patients with lymphopenia showed a longer hospital stay (19.9 vs. 15.7 days; p 0.002) and higher in-hospital mortality (26.7 vs 7.7 %; p 0.001). The odds ratio for in-hospital mortality in patients with lymphopenia was 3.9 (p 0.03) and the hazard ratio for 1-year mortality 1.9 (p 0.038). Both groups of elderly patients, with and without lymphopenia on admission, showed no differences related to sociodemographic, clinical, or other laboratory data. The study showed no difference in rate of infections between the groups. A quarter of our elderly hospitalized patients had lymphopenia on admission. Furthermore, lymphopenia seemed to constitute as a predictor for bad outcome in terms of a longer hospital stay, in-hospital mortality and 1-year mortality after discharge.

Từ khóa


Tài liệu tham khảo

Wick G, Grubeck-Loebenstein B (1997) The aging immune system: Primary and secondary alterations of immune reactivity in the elderly. Exp Ger 32:401–413

Weiskopf D, Weinberger B, Grubeck-Loebenstein B (2009) The aging of the immune system. Transpl Int 11:1041–1050

Dennis MS, Nicolson A, Lehmann AB et al (1998) Clinical associations of lymphopenia in elderly persons admitted to acute medical and psychiatric wards. Gerontology 44:168–171

Brass D, Mckay P, Scott F (2014) Investigating an incidental finding of lymphopenia. BMJ 348:g1721

Anonymous (1992) Unexplained CD4 T-lymphocyte depletion in persons without evident HIV infection—United States. MMWR Morb Mortal Wkly Rep 41:541–545

Zonios DI, Falloon J, Bennett JE et al (2008) Idiopathic CD4 lymphocytopenia: natural history and prognostic factors. Blood 112:287–294

Duncan RA, von Reyn CF, Alliegro GM et al (1993) Idiopathic CD4+ T-lymphocytopenia-four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 328:393–398

Soriano V, Hewlett I, Heredia A (1992) Idiopathic CD4+ T-lymphocytopenia. Lancet 340:607–608

Weiss SH, Klein CW, Mayur RK et al (1992) Idiopathic CD4+ T-lymphocytopenia. Lancet 340:608–609

Rae IM, Alexander HD, Crockard AD (1996) CD4 lymphopenia in very elderly people. Lancet 347:328–329

Crétel E, Veen I, Pierres A (2011) Étude du profil immunitaire de sujets âgés hospitalisés en unité de court séjour gériatrique. Rev Med Int 32:275–282

Belmin J, Ortega MN, Bruhat A (1996) CD4 lymphopenia in elderly patients. Lancet 347:911

Kaiser FE, Morley JE (1994) Idiopathic CD4+ T lymphopenia in older persons. J Am Geriatr Soc 42:1291–1294

Ogata K, Tamura H, Yokose N (1996) CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people. Lancet 347:1408

Gavazzi G, Krause KH (2002) Ageing and infection. Lancet Infect Dis 11:659–666

Chang CJ, Chen LY, Liu LK et al (2014) Lymphopenia and poor performance status as major predictors for infections among residents in long-term care facilities (LTCFs): a prospective cohort study. Arch Gerontol Geriatr 58:440–445

Wikby A, Maxson P, Olsson J et al (1998) Changes in CD8 and CD4 lymphocyte subsets, T-cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 102:187–198

Walker UA, Warnatz K (2006) Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18:389–395

Blackman MA, Woodland DL (2011) The narrowing of the CD8 T cell repertoire in old age. Curr Opin Immunol 23:537–542

Wikby A, Mansson IA, Johansson B et al (2008) The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age. Biogerontology 9:299–308

Deschasse G, Lombrail P, Steenpass V et al (2014) Association entre lymphopénie et mortalité chez les sujets ages admis en unite de medicine aiguë gériatrique. Geriatr Psychol Neuropsychiatr Vieil 12:25–33

Bender BS, Nagel JE, Adler WH et al (1986) Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. The Baltimore longitudinal study of aging. J Am Geriatr Soc 34:649–654

Ferguson FG, Wikby A, Maxson P et al (1995) Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol Biol Sci Med Sci 50:B378–B382

Izaks GJ, Remarque EJ, Becker SV et al (2003) Lymphocyte count and mortality risk in older persons. The Leiden 85-plus study. J Am Geriatr Soc 51:1461–1465